Clinical trials

  • DURVALUMAB for Advanced biliary tract cancer
  • IVONESCIMAB for Metastatic non-small cell lung cancer
  • AVACOPAN for ANCA-associated vasculitis (AAV) | Granulomatosis with polyangiitis (GPA) | Microscopic polyangiitis (MPA)
  • PEMBROLIZUMAB for Muscle-invasive bladder cancer | Urothelial carcinoma
  • ROPIVACAINE HYDROCHLORIDE MONOHYDRATE for Acute low back pain | Lumbar pain
  • PABINAFUSP ALFA for Mucopolysaccharidosis type II | Hunter syndrome
  • OXYBUTYNIN HYDROCHLORIDE for Spina bifida|Neurogenic bladder dysfunction
  • ZOLBETUXIMAB for Gastric adenocarcinoma | Gastroesophageal junction adenocarcinoma
  • ANSELAMIMAB for Amyloid light-chain (AL) amyloidosis | Cardiac amyloidosis (Mayo stage IIIa)
  • RUXOLITINIB for Acute lymphoblastic leukemia (relapsed)|Precursor B-lymphoblastic lymphoma/leukaemia (recurrent or refractory)|Precursor T-lymphoblastic lymphoma/leukaemia (recurrent or refractory)
  • Capecitabine for Pancreatic ductal adenocarcinoma (resectable)
  • Group B Streptococcus capsular polysaccharides (serotypes Ia, Ib, II, III, IV, V) conjugated to CRM197 for Group B streptococcus disease